
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. (TNXP)
WebsitePrice
Market cap
Next catalystQ1 2027, pending final FDA protocol agreementTNX-4800 — Lyme disease prevention · Trial initiationCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved
PreINDP2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
TNX-4300
PPAR-β/δ × PPAR-γ
PreINDP1P2P3FilingApproved
Approved / commercial
History / paused
TNXP PR & News
PR & News
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp.